Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文（繁體）
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Language
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Cost utility of drugs for mult...
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Permanent link
Cost utility of drugs for multiple sclerosis. Systematic review places study in contrast.
Bibliographic Details
Main Authors:
Bryant, J
,
Clegg, A
,
Milne, R
Format:
Journal article
Language:
English
Published:
2000
Holdings
Description
Similar Items
Staff View
Similar Items
Cost-utility and cost-effectiveness analysis of disease-modifying drugs of relapsing–remitting multiple sclerosis: a systematic review
by: Nasrin Abulhasanbeigi Gallehzan, et al.
Published: (2024-02-01)
Cost utility of drugs for multiple sclerosis. Methods used don't calculate true benefit.
by: Richards, R, et al.
Published: (2000)
Cost utility of drugs for multiple sclerosis. Methods used don't calculate true benefit.
by: Richards, R, et al.
Published: (2000)
A cost-utility analysis of interferon beta for multiple sclerosis.
by: Parkin, et al.
Published: (1998-01-01)
Comparing and Contrasting the Approach to Advance Care Planning in Multiple Sclerosis
by: De Luca, G, et al.
Published: (2018)